Author

ديفيد سيميلا

6 مايو 2023
العبء الحالي والمستقبلي لالتهاب الكبد B في سويسرا: دراسة نمذجة
Summary Chronic hepatitis B infection (defined as sustained detection of hepatitis B virus [HBV] surface antigen [HBsAg] protein in serum) is a leading cause of cirrhosis, hepatocellular carcinoma and liver-related deaths. A situation analysis carried out by the Swiss Federal Office of Public Health estimated the HBsAg prevalence in Switzerland to be 0.53% (95% CI: […]

Read More
8 نوفمبر 2017
تشير ديناميكيات فيروس التهاب الكبد الوبائي C بين متعاطي المخدرات عن طريق الحقن إلى أن امتصاص العلاج السنوي فوق 10% سيقضي على المرض بحلول عام 2030
Summary Background and Aims In Switzerland, the prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) has been decreasing owing to active harm reduction efforts and an aging population. Recent advances in HCV therapeutics may provide an opportunity to direct treatment to high-risk populations, with a goal of reducing HCV prevalence and […]

Read More